TNFRSF1A and Autoimmunity: Collectively, we demonstrate, using the EAE model of autoimmunity, that the novel combined approach of concomitantly inhibiting TNFR1 whilst promoting TNFR2 signalling may achieve greater beneficial effects than either approach in isolation.